Search

Your search keyword '"Daniel Rogowicz"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Daniel Rogowicz" Remove constraint Author: "Daniel Rogowicz" Search Limiters Full Text Remove constraint Search Limiters: Full Text
24 results on '"Daniel Rogowicz"'

Search Results

1. Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up

2. Neurological Complications after Transcatheter Aortic Valve Implantation Procedure

Catalog

Books, media, physical & digital resources

3. A clinical case of a 21-year-old patient with idiopathic acute exudative pericarditis

4. Subacute thyroiditis after SARS-CoV2 vaccines- a systematic review

5. Alcohol and Cardiovascular Diseases—Do the Consumption Pattern and Dose Make the Difference?

6. Diagnostic and prognostic significance of alpha-defensin in patients with chronic heart failure during 2-year follow-up

7. Chocolate protects a heart and vessels

8. Non-vitamin K oral anticoagulant in the prevention and treatment of venous thromboembolism. Why betrixaban is different?

9. Hypoglycaemia as a new cardiovascular risk factor

10. How to effectively reverse life-thretening effects of non-vitamin K oral anticoagulants?

11. Ocena wartości rokowniczej osoczowego stężenia białka C-reaktywnego oznaczonego metodą o wysokiej czułości (hs-CRP) u chorych z przewlekłą niewydolnością serca = Usefulness of serum high-sensitivity C-reactive protein (hs-CRP) level as prognostic factor in patients with chronic heart failure

12. Inhibitory proproteinowej konwertazy subtylizyny/keksyny 9 nowym, przełomowym narzędziem terapeutycznym w leczeniu dyslipidemii = Proprotein convertase subtilisin/kexin type 9 inhibitors are a new, groundbreaking therapeutic tool in the treatment of dyslipidemia

13. Przewrót w leczeniu choroby niedokrwiennej serca – rola kardiologii interwencyjnej = The revolution in the treatment of ischaemic heart disease – the role of interventional cardiology

14. Przydatność rokownicza nowych markerów w przewlekłej skurczowej niewydolności serca = The prognostic usefulness of new markers in chronic systolic heart failure

15. RDW – nowy marker dla chorób sercowo-naczyniowych = RDW - a new marker for cardiovascular disease

16. Implementation of recommendations on the check of risk factors for cardiovascular diseases in patients undergoing coronary re-interventions

17. Therapeutic Drug Monitoring of Carbamazepine: A 20-Year Observational Study

18. The Clinical Significance of Drug–Food Interactions of Direct Oral Anticoagulants

19. The importance of pharmacokinetics, pharmacodynamic and repetitive use of levosimendan

20. Catestatin as a New Prognostic Marker in Stable Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up

21. Wartość oznaczania stężeń antygenu nowotworowego Ca 125 i kopeptyny w monitorowaniu terapii chorych z zaawansowaną niewydolnością serca

22. Prognostic significance of red cell distribution width and other red cell parameters in patients with chronic heart failure during two years of follow-up

23. The Interactions of Nintedanib and Oral Anticoagulants—Molecular Mechanisms and Clinical Implications

24. Procalcitonin (PCT) Predicts Worse Outcome in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF)